Market Research Reports- Consulting Analysis Crystal Market Research Continuous Glucose Monitoring Devices Market by Pr

Continuous Glucose Monitoring Devices
Market Size Is Projected To Be Around $1.1
Billion By 2025
A research study titled, “Continuous Glucose Monitoring Devices Market by Product and End User
– Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states
that the continuous glucose monitoring devices market is projected to be around $1.1 billion by
2025.
Continuous glucose monitoring (CGM) devices are used to monitor glucose level throughout day and
night. A sensor is placed under the skin which measures the glucose level in tissue fluid. A transmitter is
connected to the sensor which transfers information via wireless radio frequency. This transmitter is
connected to monitoring and display device. These devices are used to monitor blood glucose level of
diabetic patients. Diabetes is a chronic disease which is classified into type 1 and type 2. Diabetes occurs
either when the pancreas does not produce enough insulin or when the body cannot effectively use the
insulin. The symptoms of diabetes are frequent urination, blurred vision, increased thirst, rapid weight
loss, numbness or tingling sensation in hands or feet and increased hunger. Factors which increase the risk
of diabetes are ethnicity, family history of diabetes, and physical inactivity. The exact causes of type 1
diabetes are unknown. Type 1 diabetes can be caused due to complex interaction between genes and
environmental factors. The strongest risk factors for type 2 diabetes are overweight and obesity. Diabetes
can damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to disability and
premature death. People with diabetes are likely to incur disastrous personal health expenditure.
According to a study conducted by American Diabetes Association, 415 million people worldwide
suffered from diabetes and diabetes related complications as of 2015, and this number is expected to
reach 642 million by 2040. Over the past three decades, the predominance of diabetes is increasing, but it